サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1496078

呼吸器インターベンションの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、適応症別、エンドユーザー別、地域別

Interventional Pulmonology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日
ページ情報
英文 270 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
呼吸器インターベンションの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、適応症別、エンドユーザー別、地域別
出版日: 2024年06月12日
発行: Fairfield Market Research
ページ情報: 英文 270 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の呼吸器インターベンションの市場規模は、2024年までに13億米ドルに達すると予測されており、今後著しい成長を遂げようとしています。同市場は5％のCAGRで拡大し、2031年には18億5,000万米ドルに達する見込みです。この力強い成長の原動力は、慢性閉塞性肺疾患（COPD）の有病率の上昇と、高度な診断・治療オプションに対する需要の高まりです。

COPDは、慢性気管支炎や喘息などの疾患を含む慢性かつ進行性の疾患であり、世界的に大きな健康上の懸念となっています。世界保健機関（WHO）によると、2019年には323万人がCOPDで死亡し、世界で3番目に多い死因となっています。特筆すべきは、70歳未満のCOPD関連死の90％近くが低・中所得国で発生していることです。COPDの罹患率の上昇は、介入的肺処置の需要を増加させ、それによって市場の成長を促進すると予想されます。

世界人口の高齢化が進み、呼吸器疾患やその他の関連疾患を持つ人の数が増加しています。平均寿命が延びるにつれて、65歳を超える人の割合も増加し、呼吸器インターベンション手技に対する需要の高まりにつながっています。このような人口動態の変化は、長期的な市場拡大に寄与すると予想されます。

当レポートでは、世界の呼吸器インターベンション市場について調査し、市場の概要とともに、製品別、適応症別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 価格分析、2019年～2023年

第4章 世界の呼吸器インターベンション市場の見通し、2019年～2031年

  • 世界の呼吸器インターベンション市場の見通し、製品別、金額（10億米ドル）、数量（台）、2019年～2031年
  • 世界の呼吸器インターベンション市場の見通し、適応症別、金額（10億米ドル）、数量（台）、2019年～2031年
  • 世界の呼吸器インターベンション市場の見通し、エンドユーザー別、金額（10億米ドル）、数量（台）、2019年～2031年
  • 世界の呼吸器インターベンション市場の見通し、地域別、金額（10億米ドル）、数量（台）、2019年～2031年

第5章 北米の呼吸器インターベンション市場の見通し、2019年～2031年

第6章 欧州の呼吸器インターベンション市場の見通し、2019年～2031年

第7章 アジア太平洋の呼吸器インターベンション市場の見通し、2019年～2031年

第8章 ラテンアメリカの呼吸器インターベンション市場の見通し、2019年～2031年

第9章 中東・アフリカの呼吸器インターベンション市場の見通し、2019年～2031年

第10章 競合情勢

  • 製品と適応症のヒートマップ
  • 企業市場シェア分析、2023年
  • 競争ダッシュボード
  • 企業プロファイル
    • Medtronic Plc
    • Boston Scientific Corporation
    • Olympus Corporation
    • FUJIFILM Corporation
    • Becton, Dickinson and Company
    • Smith's Group Plc
    • Cook Medical
    • Vygon
    • Clarus Medical LLC
    • Huger Medical Instrument Co. Ltd
    • Taewoong Medical Co. Ltd.
    • Shanghai AoHua Photoelectricity Endoscope Co., Ltd

第11章 付録

目次

The global interventional pulmonology market, projected to achieve revenues of US$ 1.3 billion by 2024, is poised for significant growth. With a compound annual growth rate (CAGR) of 5%, the market is expected to reach a valuation of US$ 1.85 billion by 2031. This robust growth is fueled by the increasing prevalence of chronic obstructive pulmonary disease (COPD) and the escalating demand for advanced diagnostic and treatment options.

Increasing COPD Incidence Driving Market Growth

COPD, a chronic and progressive condition encompassing disorders such as chronic bronchitis and asthma, is a major health concern globally. According to the World Health Organization (WHO), 3.23 million individuals died from COPD in 2019, making it the third most common cause of death worldwide. Notably, nearly 90% of COPD-related deaths in people under the age of 70 occur in low- and middle-income nations. The rising incidence of COPD is expected to increase the demand for interventional pulmonary procedures, thereby driving market growth.

Impact of Smoking on COPD Rates

The American Lung Association highlights that the majority of COPD cases are caused by smoking cigarettes. Current smokers are seven times more likely to develop COPD, while former smokers are five times more likely compared to non-smokers. The widespread use of tobacco and nicotine-based smoking products contributes significantly to lung health issues. This escalating demand for diagnosis and treatment options for lung illnesses is expected to boost the interventional pulmonology market.

Aging Population and Respiratory Disorders

The global population is aging, and the number of individuals with respiratory disorders and other associated conditions is rising. As life expectancy increases, the proportion of individuals over 65 also grows, leading to higher demand for interventional pulmonary procedures. This demographic shift is expected to contribute to market expansion over time.

Factors Driving Market Growth Over the Forecast Period

Increasing Healthcare Spending and Improving Healthcare Infrastructure

Enhanced healthcare infrastructure and increased healthcare expenditures by public bodies are supporting the adoption and use of advanced medical devices in healthcare facilities. This trend is expected to drive the demand for interventional pulmonology procedures. Emerging economies such as India, Brazil, and Mexico, which have high COPD patient populations, present significant opportunities for market growth. Economic development and rising disposable income in these regions are expected to secure the market's long-term viability.

Advancement in Technology

Technological advancements in interventional pulmonology devices are expected to enhance the outcomes of pulmonary procedures. Manufacturers are incorporating advanced unreactive materials, such as silicon coatings, to prevent microbial film formation on bronchoscopes. Additionally, extra-thin manufacturing processes and higher-resolution cameras are being used to improve bronchoscopy techniques. These innovations are expected to uplift the market.

Manufacturers are also developing insertion tubes that can be easily rotated to reduce practitioner stress and fatigue. The miniaturization of endoscopic equipment and the introduction of ultra-slim designs for observing thin bronchi are among the strategies being employed to improve device performance.

Rising Demand for Improved Bronchoscopy Techniques

Technological advancements in bronchoscopy are contributing to the growth of the global interventional pulmonology market. Improvements in electronics and microtechnology have led to safer and more accurate diagnoses of lung disorders, resulting in better patient outcomes. The demand for advanced bronchoscopy techniques is expected to drive market growth throughout the forecast period.

Challenges Facing the Interventional Pulmonology Market

Lack of Awareness Regarding Symptoms of Asthma and COPD

A significant challenge facing the market is the lack of awareness about the symptoms of asthma and COPD. Many individuals with respiratory illnesses remain undiagnosed and untreated, particularly in low-income countries. This lack of awareness is a major impediment to market growth.

Availability of Non-Invasive Options and Strict Regulations

The development of non-invasive diagnostic techniques, such as liquid biopsies and magnetic resonance spectroscopy, poses a challenge to the growth of the interventional pulmonology market. Additionally, stringent regulatory requirements, such as pre-market approval (PMA) for Class III devices by the FDA, add to the market's challenges. The rigorous approval processes and the need for clinical evidence for high-risk devices are hindering market expansion.

Associated Side Effects of Bronchoscopy Procedures

Bronchoscopy procedures carry risks such as contamination, infection, bleeding, breathing difficulties, and low blood oxygen levels. These complications reduce the adoption rates of bronchoscopy techniques. The advent of methicillin-resistant Staphylococcus aureus and other resistant bacteria has increased the likelihood of post-bronchoscopy infections, further limiting market growth.

Country-Wise Insights

Why is the U.S. Market Booming?

Increasing Prevalence of Asthma

In 2022, the U.S. accounted for approximately 90.7% of the North American interventional pulmonology market. According to the Asthma and Allergy Foundation of America, around 25 million people in the U.S. suffer from asthma, which corresponds to about 1 in every 13 individuals. This high prevalence of asthma is driving the demand for interventional pulmonology procedures.

Will Germany Be a Lucrative Market for Interventional Pulmonology Manufacturers?

Rising Cases of COPD

Germany holds an 18.3% market share in Europe. An estimated 10-12% of German adults over the age of 40 have COPD. By 2030, the number of COPD patients in Germany is expected to rise to 7.9 million from 6.8 million in 2010. Smoking and occupational air pollution are significant contributors to respiratory illnesses in the country, making COPD one of the most prevalent disorders.

How is China Emerging as a Prominent Market for Interventional Pulmonology?

Growing Geriatric Population

In 2022, China held a market share of about 52.8% of the East Asian interventional pulmonology market. WHO estimates indicate that China has one of the world's fastest-growing aging populations. By 2040, 28% of China's population is expected to be over 60. This large geriatric population, coupled with rising respiratory ailments, presents lucrative growth opportunities for the interventional pulmonology market.

Key Industry Players:

  • Medtronic Plc
  • Boston Scientific Corporation
  • Olympus Corporation
  • FUJIFILM Corporation
  • Becton, Dickinson and Company
  • Smith's Group Plc
  • Cook Medical
  • Vygon
  • Clarus Medical LLC
  • Huger Medical Instrument Co. Ltd
  • Taewoong Medical Co. Ltd.
  • Shanghai AoHua Photoelectricity Endoscope Co., Ltd
  • Karl Storz
  • Richard Wolf Corporation
  • PENTAX Medical

Market Segmentation

By Product:

  • Bronchoscopes
    • Fiberoptic (flexible) Bronchoscope
    • Rigid bronchoscope
    • Endobronchial Ultrasound Bronchoscope (EBUS)
  • Convex EBUS
  • Radial EBUS
  • Respiratory Endotherapy Devices
    • Aspiration Needles
    • Biopsy Forceps
    • Other
  • ENB Systems
  • Pleuroscopes
    • Semi flexible Pleuroscopes
    • Rigid Pleuroscopes
  • Airway Stents
  • Bronchial Thermoplasty Systems
  • Pleural Catheters
  • Endobronchial Valves

By Indication:

  • Lung Cancer
  • Asthma
  • COPD
  • Foreign Body Extraction
  • Tracheal and Bronchial Stenosis
  • Others

By End User:

  • Hospitals
  • Pulmonology Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

"

Table of Contents

1. Executive Summary

  • 1.1. Global Interventional Pulmonology Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Interventional Pulmonology Products Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Interventional Pulmonology Market Outlook, 2019 - 2031

  • 4.1. Global Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Bronchoscopes
        • 4.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 4.1.1.1.2. Rigid bronchoscope
        • 4.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 4.1.1.1.3.1. Convex EBUS
          • 4.1.1.1.3.2. Radial EBUS
      • 4.1.1.2. Respiratory Endotherapy Devices
        • 4.1.1.2.1. Aspiration Needles
        • 4.1.1.2.2. Biopsy Forceps
        • 4.1.1.2.3. Other
      • 4.1.1.3. ENB Systems
      • 4.1.1.4. Pleuroscopes
        • 4.1.1.4.1. Semi flexible Pleuroscopes
        • 4.1.1.4.2. Rigid Pleuroscopes
      • 4.1.1.5. Airway Stents
      • 4.1.1.6. Bronchial Thermoplasty Systems
      • 4.1.1.7. Pleural Catheters
      • 4.1.1.8. Endobronchial Valves
  • 4.2. Global Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Lung Cancer
      • 4.2.1.2. Asthma
      • 4.2.1.3. COPD
      • 4.2.1.4. Foreign Body Extraction
      • 4.2.1.5. Tracheal and Bronchial Stenosis
      • 4.2.1.6. Others
  • 4.3. Global Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Pulmonology Clinics
      • 4.3.1.3. Ambulatory Surgical Centers
      • 4.3.1.4. Diagnostic Centers
  • 4.4. Global Interventional Pulmonology Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Interventional Pulmonology Market Outlook, 2019 - 2031

  • 5.1. North America Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Bronchoscopes
        • 5.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 5.1.1.1.2. Rigid bronchoscope
        • 5.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 5.1.1.1.3.1. Convex EBUS
          • 5.1.1.1.3.2. Radial EBUS
      • 5.1.1.2. Respiratory Endotherapy Devices
        • 5.1.1.2.1. Aspiration Needles
        • 5.1.1.2.2. Biopsy Forceps
        • 5.1.1.2.3. Other
      • 5.1.1.3. ENB Systems
      • 5.1.1.4. Pleuroscopes
        • 5.1.1.4.1. Semi flexible Pleuroscopes
        • 5.1.1.4.2. Rigid Pleuroscopes
      • 5.1.1.5. Airway Stents
      • 5.1.1.6. Bronchial Thermoplasty Systems
      • 5.1.1.7. Pleural Catheters
      • 5.1.1.8. Endobronchial Valves
  • 5.2. North America Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Lung Cancer
      • 5.2.1.2. Asthma
      • 5.2.1.3. COPD
      • 5.2.1.4. Foreign Body Extraction
      • 5.2.1.5. Tracheal and Bronchial Stenosis
      • 5.2.1.6. Others
  • 5.3. North America Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Pulmonology Clinics
      • 5.3.1.3. Ambulatory Surgical Centers
      • 5.3.1.4. Diagnostic Centers
  • 5.4. North America Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.2. U.S. Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.3. U.S. Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.4. Canada Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.5. Canada Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.6. Canada Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Interventional Pulmonology Market Outlook, 2019 - 2031

  • 6.1. Europe Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Bronchoscopes
        • 6.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 6.1.1.1.2. Rigid bronchoscope
        • 6.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 6.1.1.1.3.1. Convex EBUS
          • 6.1.1.1.3.2. Radial EBUS
      • 6.1.1.2. Respiratory Endotherapy Devices
        • 6.1.1.2.1. Aspiration Needles
        • 6.1.1.2.2. Biopsy Forceps
        • 6.1.1.2.3. Other
      • 6.1.1.3. ENB Systems
      • 6.1.1.4. Pleuroscopes
        • 6.1.1.4.1. Semi flexible Pleuroscopes
        • 6.1.1.4.2. Rigid Pleuroscopes
      • 6.1.1.5. Airway Stents
      • 6.1.1.6. Bronchial Thermoplasty Systems
      • 6.1.1.7. Pleural Catheters
      • 6.1.1.8. Endobronchial Valves
  • 6.2. Europe Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Lung Cancer
      • 6.2.1.2. Asthma
      • 6.2.1.3. COPD
      • 6.2.1.4. Foreign Body Extraction
      • 6.2.1.5. Tracheal and Bronchial Stenosis
      • 6.2.1.6. Others
  • 6.3. Europe Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Pulmonology Clinics
      • 6.3.1.3. Ambulatory Surgical Centers
      • 6.3.1.4. Diagnostic Centers
  • 6.4. Europe Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.2. Germany Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.3. Germany Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.4. U.K. Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.5. U.K. Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.6. U.K. Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.7. France Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.8. France Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.9. France Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.10. Italy Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.11. Italy Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.12. Italy Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.13. Turkey Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.14. Turkey Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.15. Turkey Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.16. Russia Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.17. Russia Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.18. Russia Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.19. Rest of Europe Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.20. Rest of Europe Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.21. Rest of Europe Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Interventional Pulmonology Market Outlook, 2019 - 2031

  • 7.1. Asia Pacific Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Bronchoscopes
        • 7.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 7.1.1.1.2. Rigid bronchoscope
        • 7.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 7.1.1.1.3.1. Convex EBUS
          • 7.1.1.1.3.2. Radial EBUS
      • 7.1.1.2. Respiratory Endotherapy Devices
        • 7.1.1.2.1. Aspiration Needles
        • 7.1.1.2.2. Biopsy Forceps
        • 7.1.1.2.3. Other
      • 7.1.1.3. ENB Systems
      • 7.1.1.4. Pleuroscopes
        • 7.1.1.4.1. Semi flexible Pleuroscopes
        • 7.1.1.4.2. Rigid Pleuroscopes
      • 7.1.1.5. Airway Stents
      • 7.1.1.6. Bronchial Thermoplasty Systems
      • 7.1.1.7. Pleural Catheters
      • 7.1.1.8. Endobronchial Valves
  • 7.2. Asia Pacific Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Lung Cancer
      • 7.2.1.2. Asthma
      • 7.2.1.3. COPD
      • 7.2.1.4. Foreign Body Extraction
      • 7.2.1.5. Tracheal and Bronchial Stenosis
      • 7.2.1.6. Others
  • 7.3. Asia Pacific Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Pulmonology Clinics
      • 7.3.1.3. Ambulatory Surgical Centers
      • 7.3.1.4. Diagnostic Centers
  • 7.4. Asia Pacific Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.2. China Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.3. China Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.4. Japan Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.5. Japan Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.6. Japan Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.7. South Korea Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.8. South Korea Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.9. South Korea Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.10. India Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.11. India Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.12. India Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.13. Southeast Asia Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.14. Southeast Asia Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.15. Southeast Asia Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.16. Rest of Asia Pacific Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.17. Rest of Asia Pacific Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.18. Rest of Asia Pacific Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Interventional Pulmonology Market Outlook, 2019 - 2031

  • 8.1. Latin America Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Bronchoscopes
        • 8.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 8.1.1.1.2. Rigid bronchoscope
        • 8.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 8.1.1.1.3.1. Convex EBUS
          • 8.1.1.1.3.2. Radial EBUS
      • 8.1.1.2. Respiratory Endotherapy Devices
        • 8.1.1.2.1. Aspiration Needles
        • 8.1.1.2.2. Biopsy Forceps
        • 8.1.1.2.3. Other
      • 8.1.1.3. ENB Systems
      • 8.1.1.4. Pleuroscopes
        • 8.1.1.4.1. Semi flexible Pleuroscopes
        • 8.1.1.4.2. Rigid Pleuroscopes
      • 8.1.1.5. Airway Stents
      • 8.1.1.6. Bronchial Thermoplasty Systems
      • 8.1.1.7. Pleural Catheters
      • 8.1.1.8. Endobronchial Valves
  • 8.2. Latin America Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Lung Cancer
      • 8.2.1.2. Asthma
      • 8.2.1.3. COPD
      • 8.2.1.4. Foreign Body Extraction
      • 8.2.1.5. Tracheal and Bronchial Stenosis
      • 8.2.1.6. Others
  • 8.3. Latin America Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Pulmonology Clinics
      • 8.3.1.3. Ambulatory Surgical Centers
      • 8.3.1.4. Diagnostic Centers
  • 8.4. Latin America Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.2. Brazil Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.3. Brazil Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.4. Mexico Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.5. Mexico Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.6. Mexico Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.7. Argentina Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.8. Argentina Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.9. Argentina Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.10. Rest of Latin America Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.11. Rest of Latin America Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.12. Rest of Latin America Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Interventional Pulmonology Market Outlook, 2019 - 2031

  • 9.1. Middle East & Africa Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Bronchoscopes
        • 9.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 9.1.1.1.2. Rigid bronchoscope
        • 9.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 9.1.1.1.3.1. Convex EBUS
          • 9.1.1.1.3.2. Radial EBUS
      • 9.1.1.2. Respiratory Endotherapy Devices
        • 9.1.1.2.1. Aspiration Needles
        • 9.1.1.2.2. Biopsy Forceps
        • 9.1.1.2.3. Other
      • 9.1.1.3. ENB Systems
      • 9.1.1.4. Pleuroscopes
        • 9.1.1.4.1. Semi flexible Pleuroscopes
        • 9.1.1.4.2. Rigid Pleuroscopes
      • 9.1.1.5. Airway Stents
      • 9.1.1.6. Bronchial Thermoplasty Systems
      • 9.1.1.7. Pleural Catheters
      • 9.1.1.8. Endobronchial Valves
  • 9.2. Middle East & Africa Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Lung Cancer
      • 9.2.1.2. Asthma
      • 9.2.1.3. COPD
      • 9.2.1.4. Foreign Body Extraction
      • 9.2.1.5. Tracheal and Bronchial Stenosis
      • 9.2.1.6. Others
  • 9.3. Middle East & Africa Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Pulmonology Clinics
      • 9.3.1.3. Ambulatory Surgical Centers
      • 9.3.1.4. Diagnostic Centers
  • 9.4. Middle East & Africa Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.2. GCC Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.3. GCC Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.4. South Africa Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.5. South Africa Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.6. South Africa Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.7. Egypt Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.8. Egypt Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.9. Egypt Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.10. Nigeria Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.11. Nigeria Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.12. Nigeria Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.13. Rest of Middle East & Africa Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.14. Rest of Middle East & Africa Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.15. Rest of Middle East & Africa Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Product vs Indication Heatmap
  • 10.2. Company Market Share Analysis, 2023
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Medtronic Plc
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Boston Scientific Corporation
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. Olympus Corporation
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. FUJIFILM Corporation
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Becton, Dickinson and Company
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Smith's Group Plc
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Cook Medical
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Vygon
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Clarus Medical LLC
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Product Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development
    • 10.4.10. Huger Medical Instrument Co. Ltd
      • 10.4.10.1. Company Overview
      • 10.4.10.2. Product Portfolio
      • 10.4.10.3. Financial Overview
      • 10.4.10.4. Business Strategies and Development
    • 10.4.11. Taewoong Medical Co. Ltd.
      • 10.4.11.1. Company Overview
      • 10.4.11.2. Product Portfolio
      • 10.4.11.3. Financial Overview
      • 10.4.11.4. Business Strategies and Development
    • 10.4.12. Shanghai AoHua Photoelectricity Endoscope Co., Ltd
      • 10.4.12.1. Company Overview
      • 10.4.12.2. Product Portfolio
      • 10.4.12.3. Financial Overview
      • 10.4.12.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations